Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	600	523	467	618	962	764
Market Cap Growth	107.22%	11.93%	-24.43%	-35.78%	25.98%	-
Enterprise Value	727	577	518	526	724	544
PE Ratio	-	-2.59	-2.36	-4.29	-7.45	-2.99
PS Ratio	231.30	766.45	-	-	-	-
PB Ratio	-4.18	-7.18	-6.24	8.56	4.95	3.35
P/FCF Ratio	-3.69	-3.75	-3.16	-4.15	-13.60	-20.84
P/OCF Ratio	-3.72	-3.80	-3.19	-4.16	-13.81	-20.92
EV/Sales Ratio	280.44	846.49	-	-	-	-
EV/EBITDA Ratio	-3.82	-3.63	-3.05	-3.85	-5.83	-2.17
EV/EBIT Ratio	-3.81	-3.62	-3.04	-3.84	-5.81	-2.17
EV/FCF Ratio	-4.45	-4.15	-3.51	-3.53	-10.23	-14.83
Debt / Equity Ratio	-3.05	-6.03	-2.76	1.27	0.25	0.10
Debt / EBITDA Ratio	-2.31	-2.76	-1.22	-0.67	-0.39	-0.09
Debt / FCF Ratio	-2.69	-3.15	-1.40	-0.61	-0.69	-0.64
Quick Ratio	7.57	9.95	5.94	9.69	5.18	65.04
Current Ratio	7.83	10.25	6.12	9.86	5.25	68.20
Asset Turnover	0.01	0.00	0	0	0	0
Interest Coverage	-3.94	-3.80	-6.24	-20.20	-27.17	-60.08
Return on Equity (ROE)	445.50%	494.30%	1126.60%	-121.90%	-69.00%	-225.10%
Return on Assets (ROA)	-77.50%	-76.10%	-108.40%	-65.50%	-49.50%	-197.70%
Return on Capital (ROIC)	-68.14%	-45.70%	-130.85%	-82.62%	-51.65%	-42.23%
Earnings Yield	-41.11%	-38.57%	-42.34%	-23.28%	-13.41%	-33.40%
FCF Yield	-28.07%	-26.63%	-31.60%	-24.08%	-7.35%	-4.80%
Buyback Yield / Dilution	-37.82%	-31.11%	-5.72%	-11.36%	-192.32%	-87.83%
Total Shareholder Return	-37.82%	-31.11%	-5.72%	-11.36%	-192.32%	-87.83%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).